FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226158785> ?p ?o ?g. }

• W4226158785 endingPage "230" @default.
• W4226158785 startingPage "227" @default.
• W4226158785 abstract "Transferrin receptor 1 (TfR1) is a universal cancer marker and a meaningful target for antibody-based immunotherapy. We previously developed a mouse/human chimeric antibody (ch128.1/IgG1) specific for the human TfR1 and reported that treatment of SCID-Beige mice bearing disseminated human multiple myeloma (MM) cells with ch128.1/IgG1 results in significant antitumor activity in early-stage and late-stage disease. Both bortezomib and lenalidomide are Food and Drug Administration (FDA) approved therapeutics used to treat MM in combination with other agents. Since combining treatments with different mechanisms of action is an effective antitumor strategy and given the relevance of bortezomib and lenalidomide in MM therapy, we decided to explore, for the first time, the combination of bortezomib or lenalidomide treatment with ch128.1/IgG1 within the context of late-stage MM disease. We found that treatment with a single dose of ch128.1/IgG1, or multiple doses of bortezomib or lenalidomide, used as single agents, results in significant antitumor activity in SCID-Beige mice bearing late-stage disseminated human MM.1S tumors. However, this antitumor activity is superior when ch128.1/IgG1 is combined with either bortezomib or lenalidomide, showing significantly longer survival compared with any therapy used alone. These novel results suggest that the combinations of ch128.1/IgG1 and bortezomib or lenalidomide are promising strategies against MM." @default.
• W4226158785 created "2022-05-05" @default.
• W4226158785 creator A5021174842 @default.
• W4226158785 creator A5034238749 @default.
• W4226158785 creator A5081790862 @default.
• W4226158785 creator A5090553690 @default.
• W4226158785 creator A5090912479 @default.
• W4226158785 date "2022-04-26" @default.
• W4226158785 modified "2023-09-24" @default.
• W4226158785 title "Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief Communication" @default.
• W4226158785 cites W1966525515 @default.
• W4226158785 cites W1969733242 @default.
• W4226158785 cites W1980068016 @default.
• W4226158785 cites W1989877475 @default.
• W4226158785 cites W2025656486 @default.
• W4226158785 cites W2066700805 @default.
• W4226158785 cites W2087257389 @default.
• W4226158785 cites W2101683906 @default.
• W4226158785 cites W2168813385 @default.
• W4226158785 cites W2169822818 @default.
• W4226158785 cites W2209836101 @default.
• W4226158785 cites W2464511285 @default.
• W4226158785 cites W2542880571 @default.
• W4226158785 cites W2565642046 @default.
• W4226158785 cites W2795234647 @default.
• W4226158785 cites W2797231291 @default.
• W4226158785 cites W2889810983 @default.
• W4226158785 cites W2914013902 @default.
• W4226158785 cites W2938693543 @default.
• W4226158785 cites W2960147818 @default.
• W4226158785 cites W2979810949 @default.
• W4226158785 cites W2987620553 @default.
• W4226158785 cites W3138831421 @default.
• W4226158785 cites W4210753758 @default.
• W4226158785 cites W4313310610 @default.
• W4226158785 cites W4313310663 @default.
• W4226158785 doi "https://doi.org/10.1097/cji.0000000000000419" @default.
• W4226158785 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35467582" @default.
• W4226158785 hasPublicationYear "2022" @default.
• W4226158785 type Work @default.
• W4226158785 citedByCount "0" @default.
• W4226158785 crossrefType "journal-article" @default.
• W4226158785 hasAuthorship W4226158785A5021174842 @default.
• W4226158785 hasAuthorship W4226158785A5034238749 @default.
• W4226158785 hasAuthorship W4226158785A5081790862 @default.
• W4226158785 hasAuthorship W4226158785A5090553690 @default.
• W4226158785 hasAuthorship W4226158785A5090912479 @default.
• W4226158785 hasBestOaLocation W42261587852 @default.
• W4226158785 hasConcept C126322002 @default.
• W4226158785 hasConcept C143998085 @default.
• W4226158785 hasConcept C150903083 @default.
• W4226158785 hasConcept C207001950 @default.
• W4226158785 hasConcept C22814914 @default.
• W4226158785 hasConcept C2776063141 @default.
• W4226158785 hasConcept C2776364478 @default.
• W4226158785 hasConcept C2776999253 @default.
• W4226158785 hasConcept C2777478702 @default.
• W4226158785 hasConcept C2778367456 @default.
• W4226158785 hasConcept C2779609412 @default.
• W4226158785 hasConcept C32264632 @default.
• W4226158785 hasConcept C502942594 @default.
• W4226158785 hasConcept C71924100 @default.
• W4226158785 hasConcept C86803240 @default.
• W4226158785 hasConcept C98274493 @default.
• W4226158785 hasConceptScore W4226158785C126322002 @default.
• W4226158785 hasConceptScore W4226158785C143998085 @default.
• W4226158785 hasConceptScore W4226158785C150903083 @default.
• W4226158785 hasConceptScore W4226158785C207001950 @default.
• W4226158785 hasConceptScore W4226158785C22814914 @default.
• W4226158785 hasConceptScore W4226158785C2776063141 @default.
• W4226158785 hasConceptScore W4226158785C2776364478 @default.
• W4226158785 hasConceptScore W4226158785C2776999253 @default.
• W4226158785 hasConceptScore W4226158785C2777478702 @default.
• W4226158785 hasConceptScore W4226158785C2778367456 @default.
• W4226158785 hasConceptScore W4226158785C2779609412 @default.
• W4226158785 hasConceptScore W4226158785C32264632 @default.
• W4226158785 hasConceptScore W4226158785C502942594 @default.
• W4226158785 hasConceptScore W4226158785C71924100 @default.
• W4226158785 hasConceptScore W4226158785C86803240 @default.
• W4226158785 hasConceptScore W4226158785C98274493 @default.
• W4226158785 hasIssue "5" @default.
• W4226158785 hasLocation W42261587851 @default.
• W4226158785 hasLocation W42261587852 @default.
• W4226158785 hasLocation W42261587853 @default.
• W4226158785 hasOpenAccess W4226158785 @default.
• W4226158785 hasPrimaryLocation W42261587851 @default.
• W4226158785 hasRelatedWork W1555911559 @default.
• W4226158785 hasRelatedWork W1974798389 @default.
• W4226158785 hasRelatedWork W2044144069 @default.
• W4226158785 hasRelatedWork W2044477514 @default.
• W4226158785 hasRelatedWork W2048530112 @default.
• W4226158785 hasRelatedWork W2098422029 @default.
• W4226158785 hasRelatedWork W2339661511 @default.
• W4226158785 hasRelatedWork W2783534173 @default.
• W4226158785 hasRelatedWork W3082792137 @default.
• W4226158785 hasRelatedWork W4226158785 @default.
• W4226158785 hasVolume "45" @default.
• W4226158785 isParatext "false" @default.

• next